Voiding Pattern Analysis as a Surrogate for Cystometric Evaluation in Uroplakin II Knockout Mice

Journal of Urology

Volumn 179, Issue 5, 2008, Pages 2046-2051

  Hodges, Steve J ^a   Zhou, Ge ^b   Deng, Fang Ming ^b   Aboushwareb, Tamer ^a   Turner, Chanda ^a   Andersson, Karl Erik ^a   Santago, Pete ^a   Case, Doug ^a   Sun, Tung Tien ^b   Christ, George J ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

bladder; mice; urination; uroplakin II

Indexed keywords

UNCLASSIFIED DRUG; UROPLAKIN; UROPLAKIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER FUNCTION; CONTROLLED STUDY; CYSTOMETRY; FEMALE; MALE; MICTURITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; ULTRAVIOLET SPECTROSCOPY; URINARY TRACT DISEASE; VESICOURETERAL REFLUX;

ANIMALS; FEMALE; MALE; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; URINARY BLADDER; URINATION; URODYNAMICS;

EID: 41749116381     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.12.039     Document Type: Article

References (20)

1. Group BRPR. Overcoming Bladder Disease: A Strategic Plan for Research (2002), National Institutes of Health, Bethesda
2. Abrams P., Cardozo L., Fall M., Griffiths D., Rosier P., Ulmsten U., et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21 (2002) 167
3. Irwin D.E., Milsom I., Hunskaar S., Reilly K., Kopp Z., Herschorn S., et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 50 (2006) 1306
4. Milsom I., Abrams P., Cardozo L., Roberts R.G., Thuroff J., and Wein A.J. How widespread are the symptoms of an overactive bladder and how are they managed?. A population-based prevalence study. BJU Int 87 (2001) 760
5. Stewart W.F., Van Rooyen J.B., Cundiff G.W., Abrams P., Herzog A.R., Corey R., et al. Prevalence and burden of overactive bladder in the United States. World J Urol 20 (2003) 327
6. Andersson K.E. Antimuscarinics for treatment of overactive bladder. Lancet Neurol 3 (2004) 46
7. Hu T.W., Wagner T.H., Hawthorne G., Moore K., Subak L.L., and Versi E. Economics of Incontinence. In: Abrams P., Cardozo L., Khoury S., and Wein A. (Eds). 3rd International Consultation on Incontinence (2005), Health Publications Ltd, Paris 75-95
8. Andersson K.E. Current concepts in the treatment of disorders of micturition. Drugs 35 (1988) 477
9. Andersson K.E., Appell R., Cardozo L., Chapple C., Drutz H., Fourcroy J., et al. Incontinence. In: Abrams P., Cardozo L., Khoury S., and Wein A. (Eds). 3rd International Consultation on Incontinence (2005), Health Publications Ltd, Paris 811-854
10. Hu P., Deng F.M., Liang F.X., Hu C.M., Auerbach A.B., Shapiro E., et al. Ablation of uroplakin III gene results in small urothelial plaques, urothelial leakage, and vesicoureteral reflux. J Cell Biol 151 (2000) 961
11. Kong X.T., Deng F.M., Hu P., Liang F.X., Zhou G., Auerbach A.B., et al. Roles of uroplakins in plaque formation, umbrella cell enlargement, and urinary tract diseases. J Cell Biol 167 (2004) 1195
12. Wu X.R., Manabe M., Yu J., and Sun T.T. Large scale purification and immunolocalization of bovine uroplakins I, II, and III Molecular markers of urothelial differentiation. J Biol Chem 265 (1990) 19170
13. Yu J., Manabe M., Wu X.R., Xu C., Surya B., and Sun T.T. Uroplakin I: a 27-kD protein associated with the asymmetric unit membrane of mammalian urothelium. J Cell Biol 111 (1990) 1207
14. Christ G.J., Day N.S., Santizo C., Zhao W., Sclafani T., Karicheti V., et al. Bladder instillation of "naked" hSlo/pcDNA3 ameliorates detrusor hyperactivity in obstructed rats in vivo. Urology 57 (2001) 111
15. Pandita R.K., Fujiwara M., Alm P., and Andersson K.E. Cystometric evaluation of bladder function in non-anesthetized mice with and without bladder outlet obstruction. J Urol 164 (2000) 1385
16. Woodman S.E., Cheung M.W., Tarr M., North A.C., Schubert W., Lagaud G., et al. Urogenital alterations in aged male caveolin-1 knockout mice. J Urol 171 (2004) 950
17. Christ G.J., Hsieh Y., Zhao W., Schenk G., Venkateswarlu K., Wang H.Z., et al. Effects of streptozotocin-induced diabetes on bladder and erectile (dys)function in the same rat in vivo. BJU Int 97 (2006) 1076
18. Horvath G., Morvay Z., Kovacs M., Szikszay M., and Benedek G. An ultrasonographic method for the evaluation of dexmedetomidine on micturition in intact rats. J Pharmacol Toxicol Methods 32 (1994) 215
19. Stewart F.A. Mechanism of bladder damage and repair after treatment with radiation and cytostatic drugs. Br J Cancer Suppl 7 (1986) 280
20. Wood R., Eichel L., Messing E.M., and Schwarz E. Automated noninvasive measurement of cyclophosphamide-induced changes in murine micturition frequency and volume and demonstration of pharmacologic sensitivity. Urology 57 (2001) 115